Jaguar Health, Inc. (JAGX) - Form 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Jaguar Health, Inc. on February 18, 2026. The filing discloses a material modification to the rights of security holders and other events regarding a special one-time dividend declaration by the Board of Directors.
Key Financial Metrics
The filing does not provide specific financial performance metrics such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on the terms of a new equity issuance.
Material Changes and Corporate Actions
- Special Dividend Declaration: The Board declared a special one-time dividend of one-tenth (1/10th) of one share of Series O Convertible Preferred Stock for each share of Common Stock outstanding.
- Eligibility: The dividend applies to Common Stock and certain Eligible Warrants (covering 2,400,765 shares) outstanding as of the Record Date.
- Key Dates:
- Record Date: March 2, 2026.
- Payment Date: Expected March 4, 2026.
- Series O Preferred Stock Terms:
- Dividends: No cash dividends are payable on the Series O Preferred Stock.
- Voting Rights: Generally no voting rights, except one vote per 1/10th share on matters where holders are entitled to vote.
- Liquidation Preference: Holders are entitled to $0.0001 per share before Common Stock holders in a liquidation event, subject to creditor rights.
- Transfer Restrictions: Shares cannot be transferred, assigned, or pledged without prior written consent from the Company.
- Trading: No established trading market exists, and the Company does not intend to list the Series O Preferred Stock on any exchange.
- Conversion Mechanics:
- Optional Conversion: The Company may elect to convert all outstanding Series O shares to Common Stock at any time prior to December 31, 2026.
- Automatic Conversion: If not converted earlier, all shares automatically convert on December 31, 2026.
- Conversion Price: Based on the "Minimum Price," defined as the lower of the closing price immediately preceding the conversion date or the average closing price of the five trading days preceding that date.
- Ownership Cap: Conversion is subject to a "Maximum Percentage" limitation of 19.99% beneficial ownership. Excess shares may be issued as Pre-Funded Warrants.
Guidance, Risks, and Contingencies
The Company is supplementing its previously disclosed risk factors with new risks related to the Preferred Stock Dividend, as detailed in Exhibit 99.2. The filing notes that the Series O Preferred Stock will not trade with the Common Stock and lacks an established market. Investors are advised to consult brokers regarding entitlement to the dividend during the trading period between the announcement and the record date.
Investor Verification Checklist
- Verify the exact number of Common Stock and Eligible Warrants held as of the March 2, 2026 Record Date to determine dividend entitlement.
- Review the full text of the Certificate of Designation (Exhibit 3.1) for detailed conversion formulas and liquidation scenarios.
- Assess the impact of the 19.99% beneficial ownership cap on potential conversion outcomes for large shareholders.
- Confirm the lack of liquidity for the Series O Preferred Stock prior to its mandatory or optional conversion to Common Stock.
- Monitor the Company's stock price leading up to the conversion date, as it directly determines the conversion ratio via the "Minimum Price" mechanism.